Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.

MLA

Jenks, Jeffrey D., et al. “Study Protocol: A Randomized, Double-Blind, Placebo-Controlled Trial of Isavuconazole Prophylaxis for the Prevention of Covid-19-Associated Pulmonary Aspergillosis.” Contemporary Clinical Trials Communications, vol. 39, May 2024, p. 101310. EBSCOhost, https://doi.org/10.1016/j.conctc.2024.101310.

APA

Jenks, J. D., Hoenigl, M., & Thompson, G. R. (2024). Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis. Contemporary Clinical Trials Communications, 39, 101310. https://doi.org/10.1016/j.conctc.2024.101310

Chicago

Jenks, Jeffrey D, Martin Hoenigl, and George R Thompson. 2024. “Study Protocol: A Randomized, Double-Blind, Placebo-Controlled Trial of Isavuconazole Prophylaxis for the Prevention of Covid-19-Associated Pulmonary Aspergillosis.” Contemporary Clinical Trials Communications 39 (May): 101310. doi:10.1016/j.conctc.2024.101310.